vs
Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
CBAK Energy Technology, Inc. is the larger business by last-quarter revenue ($58.8M vs $57.6M, roughly 1.0× Phathom Pharmaceuticals, Inc.). On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs 94.1%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $-167.0M).
CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
CBAT vs PHAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.8M | $57.6M |
| Net Profit | $-7.4M | — |
| Gross Margin | 7.3% | 86.7% |
| Operating Margin | -13.6% | — |
| Net Margin | -12.5% | — |
| Revenue YoY | 131.8% | 94.1% |
| Net Profit YoY | -63.6% | 71.6% |
| EPS (diluted) | $-0.08 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.8M | $57.6M | ||
| Q3 25 | $60.9M | $49.5M | ||
| Q2 25 | $40.5M | $39.5M | ||
| Q1 25 | $34.9M | $28.5M | ||
| Q4 24 | $25.4M | $29.7M | ||
| Q3 24 | $44.6M | $16.4M | ||
| Q2 24 | $47.8M | $7.3M | ||
| Q1 24 | $58.8M | — |
| Q4 25 | $-7.4M | — | ||
| Q3 25 | $2.7M | $-30.0M | ||
| Q2 25 | $-3.1M | $-75.8M | ||
| Q1 25 | $-1.6M | $-94.3M | ||
| Q4 24 | $-4.5M | — | ||
| Q3 24 | $17.6K | $-85.6M | ||
| Q2 24 | $6.4M | $-91.4M | ||
| Q1 24 | $9.8M | — |
| Q4 25 | 7.3% | 86.7% | ||
| Q3 25 | 8.0% | 87.5% | ||
| Q2 25 | 11.0% | 87.2% | ||
| Q1 25 | 13.7% | 86.9% | ||
| Q4 24 | 13.1% | 87.1% | ||
| Q3 24 | 15.6% | 85.6% | ||
| Q2 24 | 26.6% | 81.2% | ||
| Q1 24 | 31.9% | — |
| Q4 25 | -13.6% | — | ||
| Q3 25 | -6.6% | -30.8% | ||
| Q2 25 | -8.7% | -151.7% | ||
| Q1 25 | -8.2% | -276.5% | ||
| Q4 24 | -26.0% | — | ||
| Q3 24 | -1.9% | -433.0% | ||
| Q2 24 | 12.4% | -1055.4% | ||
| Q1 24 | 17.4% | — |
| Q4 25 | -12.5% | — | ||
| Q3 25 | 4.4% | -60.5% | ||
| Q2 25 | -7.6% | -191.9% | ||
| Q1 25 | -4.5% | -330.7% | ||
| Q4 24 | -17.8% | — | ||
| Q3 24 | 0.0% | -523.3% | ||
| Q2 24 | 13.5% | -1248.6% | ||
| Q1 24 | 16.7% | — |
| Q4 25 | $-0.08 | — | ||
| Q3 25 | $0.03 | $-0.41 | ||
| Q2 25 | $-0.03 | $-1.05 | ||
| Q1 25 | $-0.02 | $-1.31 | ||
| Q4 24 | $-0.05 | — | ||
| Q3 24 | $0.00 | $-1.32 | ||
| Q2 24 | $0.07 | $-1.56 | ||
| Q1 24 | $0.11 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.3M | $130.0M |
| Total DebtLower is stronger | $4.1M | $209.1M |
| Stockholders' EquityBook value | $112.7M | $-438.2M |
| Total Assets | $426.2M | $259.1M |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.3M | $130.0M | ||
| Q3 25 | $10.5M | $135.2M | ||
| Q2 25 | $45.7M | $149.6M | ||
| Q1 25 | $9.6M | $212.3M | ||
| Q4 24 | $11.0M | $297.3M | ||
| Q3 24 | $24.2M | $334.7M | ||
| Q2 24 | $44.1M | $276.2M | ||
| Q1 24 | $23.8M | — |
| Q4 25 | $4.1M | $209.1M | ||
| Q3 25 | $4.8M | $207.1M | ||
| Q2 25 | $4.9M | $205.1M | ||
| Q1 25 | $4.1M | $203.2M | ||
| Q4 24 | — | $201.4M | ||
| Q3 24 | — | $175.7M | ||
| Q2 24 | — | $174.4M | ||
| Q1 24 | — | — |
| Q4 25 | $112.7M | $-438.2M | ||
| Q3 25 | $121.4M | $-422.5M | ||
| Q2 25 | $118.2M | $-405.8M | ||
| Q1 25 | $120.8M | $-338.4M | ||
| Q4 24 | $121.7M | $-253.6M | ||
| Q3 24 | $131.2M | $-187.1M | ||
| Q2 24 | $126.6M | $-233.8M | ||
| Q1 24 | $120.9M | — |
| Q4 25 | $426.2M | $259.1M | ||
| Q3 25 | $363.9M | $240.3M | ||
| Q2 25 | $333.1M | $250.2M | ||
| Q1 25 | $311.5M | $294.2M | ||
| Q4 24 | $302.2M | $378.3M | ||
| Q3 24 | $293.5M | $387.0M | ||
| Q2 24 | $279.6M | $319.4M | ||
| Q1 24 | $286.5M | — |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.8M | $-166.8M |
| Free Cash FlowOCF − Capex | $16.1M | $-167.0M |
| FCF MarginFCF / Revenue | 27.3% | -290.0% |
| Capex IntensityCapex / Revenue | 23.4% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $3.9M | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.8M | $-166.8M | ||
| Q3 25 | $14.6M | $-14.1M | ||
| Q2 25 | $13.8M | $-62.7M | ||
| Q1 25 | $-9.6M | $-84.9M | ||
| Q4 24 | $9.6M | $-266.8M | ||
| Q3 24 | $19.7M | $-63.6M | ||
| Q2 24 | $2.9M | $-70.7M | ||
| Q1 24 | $7.4M | — |
| Q4 25 | $16.1M | $-167.0M | ||
| Q3 25 | $6.0M | $-14.1M | ||
| Q2 25 | $4.1M | $-62.8M | ||
| Q1 25 | $-22.3M | $-84.9M | ||
| Q4 24 | $3.9M | $-266.9M | ||
| Q3 24 | $16.5M | $-63.6M | ||
| Q2 24 | $2.5M | $-70.8M | ||
| Q1 24 | $-454.0K | — |
| Q4 25 | 27.3% | -290.0% | ||
| Q3 25 | 9.9% | -28.6% | ||
| Q2 25 | 10.2% | -159.0% | ||
| Q1 25 | -63.9% | -297.9% | ||
| Q4 24 | 15.5% | -899.8% | ||
| Q3 24 | 37.1% | -389.0% | ||
| Q2 24 | 5.2% | -966.2% | ||
| Q1 24 | -0.8% | — |
| Q4 25 | 23.4% | 0.4% | ||
| Q3 25 | 14.1% | 0.1% | ||
| Q2 25 | 23.8% | 0.2% | ||
| Q1 25 | 36.3% | 0.1% | ||
| Q4 24 | 22.5% | 0.5% | ||
| Q3 24 | 7.0% | 0.3% | ||
| Q2 24 | 0.9% | 0.6% | ||
| Q1 24 | 13.4% | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.51× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1115.72× | — | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAT
| Manufacturing Lithium Batteries | $28.0M | 48% |
| Residential Energy Supply And Uninterruptable Supplies | $17.8M | 30% |
| Light Electric Vehicles | $12.9M | 22% |
| Precursor | $108.0K | 0% |
PHAT
Segment breakdown not available.
